Your browser doesn't support javascript.
loading
Use of controlled temperature chain and compact prefilled auto-disable devices to reach 2030 hepatitis B birth dose vaccination targets in LMICs: a modelling and cost-optimisation study.
Seaman, Christopher P; Morgan, Christopher; Howell, Jess; Xiao, Yinzong; Spearman, C Wendy; Sonderup, Mark; Lesi, Olufunmilayo; Andersson, Monique I; Hellard, Margaret E; Scott, Nick.
Affiliation
  • Seaman CP; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Morgan C; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.
  • Howell J; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Parkville, VIC, Australia; Department of Gastroenterology, St Vincent's Hospital M
  • Xiao Y; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Parkville, VIC, Australia; Department of Gastroenterology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia.
  • Spearman CW; Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Sonderup M; Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Lesi O; Gastroenterology and Hepatology Unit, Lagos University Teaching Hospital, Lagos, Nigeria.
  • Andersson MI; Oxford University Hospitals National Health Service Foundation Trust, Oxford, UK; Division of Medical Virology, University of Stellenbosch, Stellenbosch, South Africa.
  • Hellard ME; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia; Peter Doherty Institute for Infection a
  • Scott N; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. Electronic address: nick.scott@burnet.edu.au.
Lancet Glob Health ; 8(7): e931-e941, 2020 07.
Article in En | MEDLINE | ID: mdl-32562649
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B Vaccines / Developing Countries / Drug Storage / Vaccination Coverage / Hepatitis B Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Determinantes_sociais_saude / Patient_preference Limits: Female / Humans / Newborn / Pregnancy Language: En Journal: Lancet Glob Health Year: 2020 Document type: Article Affiliation country: Australia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B Vaccines / Developing Countries / Drug Storage / Vaccination Coverage / Hepatitis B Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Determinantes_sociais_saude / Patient_preference Limits: Female / Humans / Newborn / Pregnancy Language: En Journal: Lancet Glob Health Year: 2020 Document type: Article Affiliation country: Australia Country of publication: Reino Unido